This dataset contains counts and rates (per 1,000,000 residents) of asthma deaths among Californians statewide and by county. The data are stratified by age group (all ages, 0-17, 18+) and reported for 3-year periods. The data are derived from the California Death Statistical Master Files, which contain information collected from death certificates. All deaths with asthma coded as the underlying cause of death (ICD-10 CM J45 or J46) are included.

Mississippi, New Hampshire, and Oklahoma were the top three leading U.S states by number of deaths due to asthma per 100,000 population as of 2022. Mississippi reported 1.6 deaths per 100,000 population with asthma as the underlying cause of death. In 2021, around 40 percent of people in the United States with asthma reported experiencing an asthma episode in the past 12 months. Prevalence As of 2022, around eight percent of individuals in the United States were reported to currently have asthma. New Hampshire and Rhode Island were the leading states by lifetime prevalence of asthma among adults in 2021. Furthermore, Rhode Island and Maine have the highest current prevalence of asthma among adults in the United States. Treatment Asthma is a chronic disease that affects the airways of the lungs, and can cause shortness of breath, tightness or pain in the chest, coughing, and wheezing. Asthma symptoms can be treated through corticosteroid inhalers, such as albuterol. The number of albuterol prescriptions in the United States was around 59 million in 2022. The current out-of-pocket cost for albuterol is eight U.S. dollars.

The rate of asthma deaths in the United States has generally decreased over time since 2001. In 2021, there were around 10.6 deaths from asthma per one million population. This statistic shows the rate of deaths due to asthma among adults and children in the U.S. from 2001-2021.

The rate of asthma deaths in the United States in 2022 was highest among those aged 80 to 84 years. This statistic shows the rate of deaths due to asthma in the U.S. in 2022, by age.

Mortality from asthma (ICD-10 J45-46 equivalent to ICD-9 493). To reduce deaths from asthma. Legacy unique identifier: P00117

In 2021, the rate of deaths due to asthma among children in the United States was higher for boys than girls. In total, the asthma death rate for children in the U.S. was two per million population. This statistic shows the rate of deaths due to asthma among children in the U.S. in 2021, by gender.

Years of life lost due to mortality from asthma (ICD-10 J45-J46). Years of life lost (YLL) is a measure of premature mortality. Its primary purpose is to compare the relative importance of different causes of premature death within a particular population and it can therefore be used by health planners to define priorities for the prevention of such deaths. It can also be used to compare the premature mortality experience of different populations for a particular cause of death. The concept of years of life lost is to estimate the length of time a person would have lived had they not died prematurely. By inherently including the age at which the death occurs, rather than just the fact of its occurrence, the calculation is an attempt to better quantify the burden, or impact, on society from the specified cause of mortality. Legacy unique identifier: P00114

Rate: Number of deaths due to asthma per 100,000 adults age 65+

Definition: Deaths rate in which asthma is the underlying cause, CD-10 codes: J45-J46

Data Sources:

1) Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File. CDC WONDER On-line Database accessed at http://wonder.cdc.gov/cmf-icd10.html

2) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

3) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

In 2023, the death rate from asthma in the United States was .8 per 100,000 population. This statistic represents the rate of death with asthma as the underlying cause in the United States from 2018 to 2023.

Rate: Number of deaths due to asthma per 100,000 adults age 65+

Definition: Deaths among adults age 65+ in which asthma is the underlying cause, CD-10 codes: J45-J46

Data Sources:

1) Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed Mortality File. CDC WONDER On-line Database accessed at http://wonder.cdc.gov/cmf-icd10.html

2) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

3) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

Around 7.7% of Americans have asthma, including 20.2 million adults and 4.6 million children. This study examines asthma mortality trends and disparities across U.S. demographic and geographic groups from 1999 to 2020. A retrospective analysis was conducted using the CDC WONDER database to examine asthma-related deaths in the U.S. from 1999 to 2020. Age-adjusted mortality rates (AAMRs) and crude mortality rates (CMRs) per 100,000 were calculated. Trends and annual percent changes (APCs) were assessed overall and stratified by sex, race, region, and age. From 1999 to 2020, the U.S. recorded 221 161 asthma-related deaths (AAMR: 3.07), mostly in medical facilities. Mortality declined from 1999 to 2018 (APC: −1.53%) but surged from 2018 to 2020 (APC: 28.63%). Females, NH Blacks, and NH American Indians had the highest mortality rates. Older adults (≥65) had the greatest burden, with younger groups showing notable increases post-2018. Rural areas and the West reported slightly higher rates than urban and other regions. Hawaii and the District of Columbia had the highest AAMRs, while Florida and Nevada had the lowest. Asthma-related mortality in the U.S. declined until 2018 but sharply increased from 2018 to 2020, with rises across all demographic groups, regions, and settings. Females, NH Blacks, and older adults consistently had higher mortality rates, while younger age groups showed recent alarming increases. Targeted interventions are urgently needed to address inequities and recent mortality surges.

In 2023, the death rate for asthma in the United States was 0.7 for the male population and .9 for the female population. This statistic represents the rate of deaths with asthma as the underlying cause in the United States from 2018 to 2023, sorted by gender.

In 2022, the rate of deaths in the U.S. due to asthma was highest among Black non-Hispanics compared to other racial and ethnic groups. This statistic shows the rate of deaths due to asthma in the U.S. in 2022, by race/ethnicity.

Users can search this database pertaining to respiratory conditions such as asthma, pneumonia, bronchitis, and tuberculosis. BackgroundThe National Occupational Respiratory Mortality System (NORMS) is developed and maintained by National Institute of Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC). This surveillance system includes respiratory conditions such as: asthma, pneumonia, bronchitis, tuberculosis, lung cancer, and silicosis, among others. User FunctionalityUsers can generate national- or occupation-specific queries. Users can gener ate tables, charts and maps containing the summary statistics such as number of deaths, crude death rates, age-adjusted death rates, and years of potential life lost (YPLL ). Users can also download the dataset and/or data queries into Microsoft Excel. Data NotesThis website provides data history regarding revisions to the dataset. Data from additional sources (i.e., population estimates, comparative standard population, and life-table values) are also available. National mortality data is derived from the National Center for Health Statistics (NCHS) multiple cause of death records. These data are updated annually since 1968, unless otherwise indicated. Data are available on national, state, and county levels. The most recent d ata available is from 2007.

BackgroundThe advanced lung cancer inflammation index (ALI), which reflects both inflammation and nutritional status, has an uncertain role in predicting outcomes for asthma patients. This study aimed to evaluate the association between ALI and mortality from all causes, as well as specific causes including cardiovascular disease (CVD) and cancer-related mortality, among individuals with asthma.MethodsWe analyzed data from 4,829 asthma patients who participated in the U.S. National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. Cox proportional hazards models were used to assess the relationship between ALI and both all-cause and cause-specific mortality, adjusting for demographic and clinical variables. Additionally, restricted cubic spline models were applied to explore potential nonlinear trends, while segmented Cox models were used to identify threshold effects. A competing risk model further examined the independent association of ALI with CVD mortality.ResultsOver a median follow-up of 7.83 years, a total of 582 deaths from all causes, 151 cardiovascular-related deaths, and 125 cancer-related deaths were recorded. An L-shaped association was observed between ALI and both all-cause and CVD mortality, with thresholds identified at 82.02 for all-cause mortality and 58.40 for CVD mortality. Compared to the lowest quartile of ALI (Q1), patients in the highest quartile (Q4) had a 49% lower risk of all-cause mortality (hazard ratio [HR] 0.51, 95% confidence interval [CI] 0.40–0.66) and a 51% reduction in CVD mortality (HR 0.49, 95% CI 0.29–0.83). This protective effect was further confirmed by the competing risk model. No significant association between ALI and cancer mortality was observed (HR 1.01, 95% CI 0.98–1.03).ConclusionALI was significantly and inversely associated with all-cause and CVD mortality in asthma patients, particularly when ALI values were below 82.02 and 58.40, respectively, where the risk of mortality was substantially lower. These findings suggest that ALI may have clinical utility in assessing prognosis for asthma patients, especially in terms of cardiovascular risk evaluation.

In 2020, 1.72 men and 2.65 women per 100,000 population died as a result of asthma in England. The West Midlands had the highest mortality rate for both genders in this year, with 3.86 women per 100,000 population dying from asthma and 2.111 men per 100,000.

In 2021, the rate of deaths due to asthma among adults in the United States was higher for women than men. In total, the asthma death rate for adults in the U.S. was 13.1 per million population. This statistic shows the rate of deaths due to asthma among adults in the U.S. in 2021, by gender.

There are 750,000 emergency department (ED) visits by children for asthma exacerbations in the United States annually. Despite changing evidence and epidemiology, there have not been recent assessments of acute asthma prevalence, management, and outcomes from pediatric EDs. This 40-center retrospective evaluation utilizes the Pediatric Hospital Information System to characterize pediatric ED asthma presentations from 2015-2020. Children 2-18 years with asthma ICD-9/10 code and receipt of albuterol were included. Demographics, Child Opportunity Index (COI), ED management, return visits, and adjusted costs were evaluated. Data were summarized using standard descriptive statistics and trends assessed using Mann-Kendall trend test. There were 414,264 encounters made by 256,209 unique patients; 21% had >1 visit in 12 months. Median age was 6 years, 61.6% male, 44.5% Black, and 68.5% publicly insured; 58.3% of visits were by patients with very low/low COI. Systemic corticosteroids were administered in 86.3% of visits; 52.7% used dexamethasone. Chest radiographs were obtained in 23% of encounters. Most (74.9%) encounters resulted in ED discharge with a downward trend of visits for exacerbations per 1,000 ED visits of -9.77, 95% CI [-9.99,-9.54], increase in disposition to intensive care unit of 2.01 [1.87,2.41] and decrease in home/other of -3.77 [-4.34,-3.20]. There was no significant trend in return visits. Total adjusted costs were ∼$900 million. ED visits for asthma remain frequent and disproportionately affect children with lower social determinants of health. Dexamethasone has not been widely adopted as corticosteroid of choice and use of ancillary testing continues, highlighting opportunities for improvement in asthma care.

Number and percentage of persons having been diagnosed with asthma, by age group and sex.

BackgroundAsthma is a common respiratory disease in children. We aimed to update information about the incidence and mortality and disability-adjusted life years (DALYs) of childhood asthma and provide evidence-based recommendations for childhood asthma prevention.MethodsData were obtained from the Global Burden of Disease (GBD) study, which was conducted from 1990 to 2019 in 204 countries. First, we estimated incidence, mortality and DALY rates of childhood asthma using a Bayesian meta-regression model. Second, we analyzed the relationship between the sociodemographic index (SDI) and DALYs in different age groups. Third, we studied changes in trends of the age-standardized DALY rate between 1990 and 2019 based on age group, SDI, and risk factors.ResultsGlobally, the number of deaths due to childhood asthma and the incidence and DALY rates were 12.9 thousand (95% UI 10.6 to 15.7), 22 million (95% UI 15 to 31), and 5.1 million (95% UI 3.4 to 7.5) in 2019, decreasing by 65.1% (95% UI 47.6 to 72.4), 5.3% (95% UI 2.6 to 8.8) and 30% (95% UI 18 to 41) from those in 1990, respectively. With the exception of high-SDI regions, the age-standardized DALY rate in all age groups in all SDI regions declined. In 2019, the age-standardized DALY rate in 1- to 4-year-old individuals was highest in low-SDI regions and that of 5- to 19-year-old individuals was highest in high-SDI regions. In contrast to low-SDI regions, individuals in high-SDI regions had a higher risk of DALYs due to asthma, except in those aged 1 to 4 years. A high body mass index (BMI) was a stronger risk factor than occupational asthmagens for childhood asthma.ConclusionOur findings provide insight into asthma prevention and treatment through the identification of key factors related to childhood asthma. Based on the data available, different risk factors according to age group and region/country suggest different prevention strategies, which is key for preventing childhood asthma.